Theriva Biologics
TOVX
TOVX
19 hedge funds and large institutions have $707K invested in Theriva Biologics in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Holders
19
Holding in Top 10
–
Calls
$2.67M
Puts
–
Top Buyers
| 1 | +$103K | |
| 2 | +$56K | |
| 3 | +$31K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$31K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$10K |
Top Sellers
| 1 | -$79K | |
| 2 | -$42.2K | |
| 3 | -$25K | |
| 4 |
SCA
Snowden Capital Advisors
New York
|
-$14.9K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$2K |